181 related articles for article (PubMed ID: 7941678)
1. [Ergospirometry in the evaluation of cardiovascular drugs].
Kleber FX; Doering W
Z Kardiol; 1994; 83 Suppl 3():89-96. PubMed ID: 7941678
[TBL] [Abstract][Full Text] [Related]
2. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors?
Münzel T; Kurz S; Drexler H
Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419
[TBL] [Abstract][Full Text] [Related]
3. [Ibopamine--clinical results].
Kleber FX
Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695
[TBL] [Abstract][Full Text] [Related]
4. [Peripheral adaptation in chronic heart failure: therapeutic implications].
Drexler H
Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
[TBL] [Abstract][Full Text] [Related]
5. [Drug treatment of heart insufficiency].
Follath F
Schweiz Med Wochenschr; 1988 Dec; 118(50):1886-91. PubMed ID: 3065935
[TBL] [Abstract][Full Text] [Related]
6. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
Thormann J; Kramer W; Dieterich HA
Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
[TBL] [Abstract][Full Text] [Related]
7. [Drug therapy of heart failure].
Follath F
Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
[TBL] [Abstract][Full Text] [Related]
8. Peripheral abnormalities in chronic heart failure.
Adamopoulos S; Coats AJ
Postgrad Med J; 1991; 67 Suppl 1():S74-9; discussion S79-80. PubMed ID: 1924083
[TBL] [Abstract][Full Text] [Related]
9. [Symptomatic treatment of chronic cardiac insufficiency].
Zannad F
Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1927-34. PubMed ID: 2125411
[TBL] [Abstract][Full Text] [Related]
10. [Congestive heart failure: from cardiac muscle to skeletal muscle].
Ferrari R; Bernocchi P; Boraso A; Visioli O
Cardiologia; 1993 Dec; 38(12 Suppl 1):45-50. PubMed ID: 8020046
[TBL] [Abstract][Full Text] [Related]
11. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
Chow MS
Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
[TBL] [Abstract][Full Text] [Related]
12. Is the efficacy of positive inotropic drugs limited to symptomatic improvement?
Baumann G; Felix SB
Herz; 1991 Sep; 16 Spec No 1():304-13. PubMed ID: 1820297
[TBL] [Abstract][Full Text] [Related]
13. [Cardiopulmonary exercise capacity before and after heart transplantation].
Sigmund M; Beck FJ; Silny J; Reupcke C; Desch U; Hanrath P
Z Kardiol; 1994; 83 Suppl 3():97-102. PubMed ID: 7941679
[TBL] [Abstract][Full Text] [Related]
14. Diuretics in cardiovascular therapy. Perusing the past, practising in the present, preparing for the future.
Taylor SH
Z Kardiol; 1985; 74 Suppl 2():2-12. PubMed ID: 3890392
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms facilitating oxygen delivery during exercise in patients with chronic heart failure].
Agostoni P; Assanelli E; Guazzi M; Grazi M; Perego GB; Lomanto M; Cattadori G; Lauri G; Marenzi G
Cardiologia; 1997 Jul; 42(7):743-50. PubMed ID: 9270180
[TBL] [Abstract][Full Text] [Related]
16. Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE).
Kleber FX; Reindl I; Wenzel M; Rodewyk P; Beil S; Kosloswki B; Doering W; Sabin GV; Hinzmann S; Winter UJ
Herz; 1993 Dec; 18 Suppl 1():424-9. PubMed ID: 8125422
[TBL] [Abstract][Full Text] [Related]
17. Circulatory regulation at rest and exercise and the functional assessment of patients with congestive heart failure.
Jennings GL; Esler MD
Circulation; 1990 Jan; 81(1 Suppl):II5-13. PubMed ID: 2403869
[TBL] [Abstract][Full Text] [Related]
18. [Abnormalities of the peripheral circulation and tolerance to exertion of patients with heart failure].
Cohen-Solal A; Aupetit JF; Guéret P; Kayanakis J; Zannad F
Arch Mal Coeur Vaiss; 1989 Apr; 82(4):593-8. PubMed ID: 2500914
[TBL] [Abstract][Full Text] [Related]
19. [Influence of medical treatments on the functional status in patients with chronic cardiac insufficiency].
Cohen-Solal A; Laperche T; Gourgon R
Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1953-5. PubMed ID: 2125415
[TBL] [Abstract][Full Text] [Related]
20. Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial.
Russell SD; Selaru P; Pyne DA; Ghazzi MM; Massey KD; Pressler M; Serikoff A; Coats AJ
Am Heart J; 2003 Jan; 145(1):179-86. PubMed ID: 12514672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
